Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA).
Breast cancer
Breast-conserving surgery
Magnetic resonance imaging
Mastectomy
Reoperation
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
05
06
2021
accepted:
02
08
2021
revised:
20
07
2021
pubmed:
14
10
2021
medline:
15
2
2022
entrez:
13
10
2021
Statut:
ppublish
Résumé
Preoperative breast magnetic resonance imaging (MRI) can inform surgical planning but might cause overtreatment by increasing the mastectomy rate. The Multicenter International Prospective Analysis (MIPA) study investigated this controversial issue. This observational study enrolled women aged 18-80 years with biopsy-proven breast cancer, who underwent MRI in addition to conventional imaging (mammography and/or breast ultrasonography) or conventional imaging alone before surgery as routine practice at 27 centers. Exclusion criteria included planned neoadjuvant therapy, pregnancy, personal history of any cancer, and distant metastases. Of 5896 analyzed patients, 2763 (46.9%) had conventional imaging only (noMRI group), and 3133 (53.1%) underwent MRI that was performed for diagnosis, screening, or unknown purposes in 692/3133 women (22.1%), with preoperative intent in 2441/3133 women (77.9%, MRI group). Patients in the MRI group were younger, had denser breasts, more cancers ≥ 20 mm, and a higher rate of invasive lobular histology than patients who underwent conventional imaging alone (p < 0.001 for all comparisons). Mastectomy was planned based on conventional imaging in 22.4% (MRI group) versus 14.4% (noMRI group) (p < 0.001). The additional planned mastectomy rate in the MRI group was 11.3%. The overall performed first- plus second-line mastectomy rate was 36.3% (MRI group) versus 18.0% (noMRI group) (p < 0.001). In women receiving conserving surgery, MRI group had a significantly lower reoperation rate (8.5% versus 11.7%, p < 0.001). Clinicians requested breast MRI for women with a higher a priori probability of receiving mastectomy. MRI was associated with 11.3% more mastectomies, and with 3.2% fewer reoperations in the breast conservation subgroup. • In 19% of patients of the MIPA study, breast MRI was performed for screening or diagnostic purposes. • The current patient selection to preoperative breast MRI implies an 11% increase in mastectomies, counterbalanced by a 3% reduction of the reoperation rate. • Data from the MIPA study can support discussion in tumor boards when preoperative MRI is under consideration and should be shared with patients to achieve informed decision-making.
Identifiants
pubmed: 34643778
doi: 10.1007/s00330-021-08240-x
pii: 10.1007/s00330-021-08240-x
pmc: PMC8831264
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1611-1623Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
© 2021. The Author(s).
Références
Lehman CD, Gatsonis C, Kuhl CK et al (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295–1303. https://doi.org/10.1056/NEJMoa065447
doi: 10.1056/NEJMoa065447
pubmed: 17392300
Ray KM, Hayward JH, Joe BN (2018) Role of MR imaging for the locoregional staging of breast cancer. Magn Reson Imaging Clin N Am 26:191–205. https://doi.org/10.1016/j.mric.2017.12.008
doi: 10.1016/j.mric.2017.12.008
pubmed: 29622125
Houssami N, Turner R, Macaskill P et al (2014) An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 32:392–401. https://doi.org/10.1200/JCO.2013.52.7515
doi: 10.1200/JCO.2013.52.7515
pubmed: 24395846
Houssami N, Turner RM, Morrow M (2017) Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer. Breast Cancer Res Treat 165:273–283. https://doi.org/10.1007/s10549-017-4324-3
doi: 10.1007/s10549-017-4324-3
pubmed: 28589366
pmcid: 5580248
Monticciolo DL (2017) Practical considerations for the use of breast MRI for breast cancer evaluation in the preoperative setting. Acad Radiol 24:1447–1450. https://doi.org/10.1016/j.acra.2017.05.012
doi: 10.1016/j.acra.2017.05.012
pubmed: 28647387
Sardanelli F, Newstead GM, Putz B et al (2016) Gadobutrol-enhanced magnetic resonance imaging of the breast in the preoperative setting. Invest Radiol 51:454–461. https://doi.org/10.1097/RLI.0000000000000254
doi: 10.1097/RLI.0000000000000254
pubmed: 26840494
Plana MN, Carreira C, Muriel A et al (2012) Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol 22:26–38. https://doi.org/10.1007/s00330-011-2238-8
doi: 10.1007/s00330-011-2238-8
pubmed: 21847541
Jatoi I, Benson JR (2013) The case against routine preoperative breast MRI. Futur Oncol 9:347–353. https://doi.org/10.2217/fon.12.186
doi: 10.2217/fon.12.186
Arnaout A, Catley C, Booth CM et al (2015) Use of preoperative magnetic resonance imaging for breast cancer. JAMA Oncol 1:1238–1250. https://doi.org/10.1001/jamaoncol.2015.3018
doi: 10.1001/jamaoncol.2015.3018
pubmed: 26402040
Zeng Z, Amin A, Roy A et al (2020) Preoperative magnetic resonance imaging use and oncologic outcomes in premenopausal breast cancer patients. NPJ Breast Cancer 6:49. https://doi.org/10.1038/s41523-020-00192-7
doi: 10.1038/s41523-020-00192-7
pubmed: 33083528
pmcid: 7532157
Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316. https://doi.org/10.1016/j.ejca.2010.02.015
doi: 10.1016/j.ejca.2010.02.015
pubmed: 20304629
Mann RM, Balleyguier C, Baltzer PA et al (2015) Breast MRI: EUSOBI recommendations for women’s information. Eur Radiol 25:3669–3678. https://doi.org/10.1007/s00330-015-3807-z
doi: 10.1007/s00330-015-3807-z
pubmed: 26002130
pmcid: 4636525
The American Society of Breast Surgeons (2016) Don’t routinely order breast MRI in new breast cancer patients. The American Society of Breast Surgeons, Columbia, MD, USA. Available via https://www.choosingwisely.org/societies/american-society-of-breast-surgeons/ . Accessed 01 Jun 2021
Sardanelli F, Trimboli RM, Houssami N et al (2020) Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study. Eur Radiol 30(10):5427–5436. https://doi.org/10.1007/s00330-020-06824-7
doi: 10.1007/s00330-020-06824-7
pubmed: 32377813
Newell MS, Giess CS, Argus AD et al (2018) ACR practice parameter for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. American College of Radiology, Reston, VA, USA. Available via https://www.acr.org/-/media/ACR/Files/Practice-Parameters/MR-Contrast-Breast.pdf . Accessed 01 Jun 2021
Parker A, Schroen AT, Brenin DR (2013) MRI utilization in newly diagnosed breast cancer: a survey of practicing surgeons. Ann Surg Oncol 20:2600–2606. https://doi.org/10.1245/s10434-013-2934-5
doi: 10.1245/s10434-013-2934-5
pubmed: 23515911
Lee J, Tanaka E, Eby PR et al (2017) Preoperative breast MRI: surgeons’ patient selection patterns and potential bias in outcomes analyses. AJR Am J Roentgenol 208:923–932. https://doi.org/10.2214/AJR.16.17038
doi: 10.2214/AJR.16.17038
pubmed: 28026205
McLaughlin SA (2013) Surgical management of the breast. Surg Clin North Am 93:411–428. https://doi.org/10.1016/j.suc.2012.12.006
doi: 10.1016/j.suc.2012.12.006
pubmed: 23464693
Margenthaler JA, Ollila DW (2016) Breast conservation therapy versus mastectomy: shared decision-making strategies and overcoming decisional conflicts in your patients. Ann Surg Oncol 23:3133–3137. https://doi.org/10.1245/s10434-016-5369-y
doi: 10.1245/s10434-016-5369-y
pubmed: 27464606
Tot T, Gere M (2008) Radiological–pathological correlation in diagnosing breast carcinoma: the role of pathology in the multimodality era. Pathol Oncol Res 14:173–178. https://doi.org/10.1007/s12253-008-9061-9
doi: 10.1007/s12253-008-9061-9
pubmed: 18521722
Gonzalez V, Sandelin K, Karlsson A et al (2014) Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg 38:1685–1693. https://doi.org/10.1007/s00268-014-2605-0
doi: 10.1007/s00268-014-2605-0
pubmed: 24817517
Balleyguier C, Dunant A, Ceugnart L et al (2019) Preoperative breast magnetic resonance imaging in women with local ductal carcinoma in situ to optimize surgical outcomes: results from the randomized phase III trial IRCIS. J Clin Oncol 37:885–892. https://doi.org/10.1200/JCO.18.00595
doi: 10.1200/JCO.18.00595
pubmed: 30811290
Walsh SM, Brennan SB, Zabor EC et al (2019) Does breast density increase the risk of re-excision for women with breast cancer having breast-conservation therapy? Ann Surg Oncol 26:4246–4253. https://doi.org/10.1245/s10434-019-07647-7
doi: 10.1245/s10434-019-07647-7
pubmed: 31396783
pmcid: 6868322
McCahill LE, Single RM, Aiello Bowles EJ et al (2012) Variability in reexcision following breast conservation surgery. JAMA 307:467–475. https://doi.org/10.1001/jama.2012.43
doi: 10.1001/jama.2012.43
pubmed: 22298678
Landercasper J, Borgert AJ, Fayanju OM et al (2019) Factors associated with reoperation in breast-conserving surgery for cancer: a prospective study of american society of breast surgeon members. Ann Surg Oncol 26:3321–3336. https://doi.org/10.1245/s10434-019-07547-w
doi: 10.1245/s10434-019-07547-w
pubmed: 31342360
pmcid: 6733824
Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571. https://doi.org/10.1016/S0140-6736(09)62070-5
doi: 10.1016/S0140-6736(09)62070-5
pubmed: 20159292
Peters NHGM, van Esser S, van den Bosch MAAJ et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: The MONET – Randomised controlled trial. Eur J Cancer 47:879–886. https://doi.org/10.1016/j.ejca.2010.11.035
doi: 10.1016/j.ejca.2010.11.035
pubmed: 21195605
Heil J, Breitkreuz K, Golatta M et al (2012) Do reexcisions impair aesthetic outcome in breast conservation surgery? exploratory analysis of a prospective cohort study. Ann Surg Oncol 19:541–547. https://doi.org/10.1245/s10434-011-1947-1
doi: 10.1245/s10434-011-1947-1
pubmed: 21761099
Olsen MA, Nickel KB, Margenthaler JA et al (2015) Increased risk of surgical site infection among breast-conserving surgery re-excisions. Ann Surg Oncol 22:2003–2009. https://doi.org/10.1245/s10434-014-4200-x
doi: 10.1245/s10434-014-4200-x
pubmed: 25358666
Nabhan C, Klink A, Prasad V (2019) Real-world evidence—what does it really mean? JAMA Oncol 5:781–783. https://doi.org/10.1001/jamaoncol.2019.0450
doi: 10.1001/jamaoncol.2019.0450
pubmed: 31095259